XML 59 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Financial Information for Assets and Liabilities of Businesses Held for Sale
ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALEDecember 31, 2023December 31, 2022
Cash and cash equivalents$609 $35 
Current receivables, inventories and contract assets551 495 
Non-current captive insurance investment securities570 554 
Property, plant and equipment and intangible assets - net254 232 
Valuation allowance on disposal group classified as held for sale(124)(17)
All other assets
125 76 
Assets of businesses held for sale$1,985 $1,374 
Progress collections and deferred income$1,001 $1,127 
Insurance liabilities and annuity benefits376 358 
Accounts payable, equipment project payables and other current liabilities392 371 
All other liabilities57 87 
Liabilities of businesses held for sale
$1,826 $1,944 
Schedule of Financial Information for Discontinued Operations
RESULTS OF DISCONTINUED OPERATIONS
For the year ended December 31, 2023
GE HealthCareGECASBank BPH & OtherTotal
Total revenues$— $— $— $— 
Cost of equipment and services sold— — — — 
Other income, costs and expenses(50)— (1,252)(1,301)
Earnings (loss) of discontinued operations before income taxes(50)— (1,252)(1,301)
Benefit (provision) for income taxes1,706 — 4 1,710 
Earnings (loss) of discontinued operations, net of taxes1,656 — (1,248)409 
Gain (loss) on disposal before income taxes— — 6 6 
Benefit (provision) for income taxes— — — — 
Gain (loss) on disposal, net of taxes— — 6 6 
Earnings (loss) from discontinued operations, net of taxes$1,656 $— $(1,242)$414 

For the year ended December 31, 2022
Total revenues$18,457 $— $— $18,457 
Cost of equipment and services sold(11,265)— — (11,265)
Other income, costs and expenses(4,842)— (808)(5,651)
Earnings (loss) of discontinued operations before income taxes2,350 — (808)1,541 
Benefit (provision) for income taxes(521)— (32)(553)
Earnings (loss) of discontinued operations, net of taxes1,829 — (841)988 
Gain (loss) on disposal before income taxes6 (18)75 64 
Benefit (provision) for income taxes11 139 — 150 
Gain (loss) on disposal, net of taxes17 121 75 213 
Earnings (loss) from discontinued operations, net of taxes$1,846 $121 $(765)$1,202 

For the year ended December 31, 2021
Total revenues$17,717 $— $— $17,717 
Cost of equipment and services sold(10,520)(398)— (10,918)
Other income, costs and expenses(4,965)1,992 (599)(3,572)
Earnings (loss) of discontinued operations before income taxes2,233 1,594 (599)3,227 
Benefit (provision) for income taxes(521)(258)(77)(856)
Earnings (loss) of discontinued operations, net of taxes1,711 1,336 (676)2,371 
Gain (loss) on disposal before income taxes12 (3,312)65 (3,234)
Benefit (provision) for income taxes2 (570)(38)(606)
Gain (loss) on disposal, net of taxes14 (3,882)27 (3,841)
Earnings (loss) from discontinued operations, net of taxes$1,726 $(2,546)$(649)$(1,469)

The tax benefit for the year ended December 31, 2023 for GE HealthCare relates to retroactive 2023 IRS guidance concerning foreign tax credits and accounting method changes and completion of the 2022 U.S. federal tax return as well as net tax benefit resulting from preparatory steps for the spin-off.
ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONSDecember 31, 2023December 31, 2022
Cash, cash equivalents and restricted cash
$1,396 $2,627 
Current receivables14 3,361 
Inventories, including deferred inventory costs— 2,512 
Goodwill— 12,799 
Other intangible assets - net— 1,520 
Contract and other deferred assets— 854 
Financing receivables held for sale (Polish mortgage portfolio)(a)
— 1,200 
 Property, plant and equipment - net 58 2,379 
All other assets
200 2,109 
Deferred income taxes27 2,528 
Assets of discontinued operations$1,695 $31,890 
Accounts payable and equipment project payables$36 $3,487 
Progress collections and deferred income— 2,499 
Long-term borrowings— 8,273 
Non-current compensation and benefits31 5,658 
All other liabilities(a)
1,125 4,556 
Liabilities of discontinued operations
$1,193 $24,474 
(a) Included $1,963 million and $848 million of valuation allowances against Financing receivables held for sale, of which $1,712 million and $611 million related to estimated borrower litigation losses, and $957 million and $748 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of December 31, 2023 and December 31, 2022, respectively. Accordingly, total estimated losses related to borrower litigation were $2,669 million and $1,359 million as of December 31, 2023 and December 31, 2022, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of December 31, 2023.